Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Feature Articles
10/31/2023
Coherus Rejects 'Heavily Discounted' Pricing on Loqtorzi, the First Ch...
10/29/2023
2023 Outlook for China's NRDL (Simon Kucher)
10/26/2023
Patent Linkage In China: What Do The First Decisions Tell Us About The...
10/24/2023
Infographic: Rare diseases in China (Research Partnership)
10/17/2023
China: The New Frontier for Western CDMOs? (Contract Pharma)
10/15/2023
The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
10/15/2023
Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
10/12/2023
China's Vast Opportunities In Health Care Attract Global Telemedicine ...
10/10/2023
China Market Opportunities for International Pharmas (Lek)
10/9/2023
MNCs Wary of Pouring Big Investments in China While Actively Seeking L...
10/3/2023
As Another New Normal of China Healthcare Dawns, Pharma MNCs Need to C...
9/28/2023
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmace...
9/26/2023
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
9/26/2023
Patent Linkage In China: What The First Decisions Reveal About The Dir...
9/24/2023
Improving Access to Medicines and Beyond: the National Volume-based Pr...
9/24/2023
Strategies for Asian Business Navigating a New Era (McKinsey)
9/20/2023
Chinese Drugmakers Hit a Fundraising and Licensing Slump in August (Ph...
9/19/2023
Researchers Must Navigate Thorny New Data Security Laws (UWN)
9/17/2023
In China's Changing Economy, MNCs Must Rethink the Mantra of Going Big...
9/15/2023
IQVIA: Review of Chinese PD-L1 Drug Market in H1/2023
9/15/2023
U.S. and Other Foreign Venture Firms Pull Back From China's Biotech Se...
9/14/2023
U.S.-China Track II Dialogue on Healthcare - July 2023 Consensus
9/13/2023
Are China's Healthcare and Biopharma Sectors Really Open for Investmen...
9/8/2023
Ageing Hong Kong Can Be the Greater Bay Area's Pensions and Healthcare...
8/31/2023
China Squeezes Healthcare Swamp with Crackdown and Cost Containment am...
8/31/2023
Discussion of Support Issue of Biological Sequence Claims from an Inva...
8/30/2023
How to Reduce the Risk of Pharmaceutical Patent Application in China?
8/29/2023
Mounjaro's China Approval Imminent as Domestic Competitors Enter Clini...
8/28/2023
Regulation of Drug and Medical Device Advertising in China: An Industr...
8/25/2023
Patent Linkage in China: What the First Decisions Reveal About the Dir...
Page:
4
/
7
Total number of articles:
189
:
[First]
[<<]
[2]
[3]
[4]
[5]
[6]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit